Salt CompositionAmbroxol 15mg + Guaifenesin 50mg + Terbutaline 2.5mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Cough with mucus
Customers also bought
More About Cufryth M 15/50/2.5mg Tablet 10s
Benefits
In Cough with mucus : Cufryth M 15mg/50mg/2.5mg Tablet gives relief from cough with mucus. It helps to loosen thick mucus, reduce its stickiness and makes it easier to cough out. This makes breathing easy and reduces the frequency of coughing. Cufryth M 15mg/50mg/2.5mg Tablet will also relieve allergy symptoms like watery eyes, sneezing, runny nose or throat irritation. Along with medications, drink enough luke warm water and gargle with warm salt water to ease the symptoms.
Side Effects
Side effects of Cufryth M Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Cufryth MNausea Vomiting Diarrhea Dizziness Headache Rash Tremors Increased heart rate Indigestion Bloating Upper abdominal pain Urticaria Itching Sweating
How to use
How to use Cufryth M Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Cufryth M 15mg/50mg/2.5mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Cufryth M Tablet works Cufryth M 15mg/50mg/2.5mg Tablet is a combination of three medicines: Ambroxol, Guaifenesin and Terbutaline, which relieves cough with mucus.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Cufryth M 15mg/50mg/2.5mg Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Cufryth M 15mg/50mg/2.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Information regarding the use of Cufryth M 15mg/50mg/2.5mg Tablet during breastfeeding is not available. Doctor consultation is advised.
Cufryth M 15mg/50mg/2.5mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Cufryth M 15mg/50mg/2.5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Cufryth M 15mg/50mg/2.5mg Tablet may be needed. Doctor consultation is advised.
Cufryth M 15mg/50mg/2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Cufryth M 15mg/50mg/2.5mg Tablet may be needed. Doctor consultation is advised.Limited information is available on the use of Cufryth M 15mg/50mg/2.5mg Tablet in these patients.
What if I forget to take it?
If a dose of Cufryth M 15mg/50mg/2.5mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
C/O RAMAN KR BHARDWAJ, KATHONI NO 825 HB NO825, PART A, TIRLOKPUR ROAD KALA AMB NARAINGARH Ambala HR 134203 IN
References
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015 (01 Apr. 2019)
ScienceDirect. Guaifenesin (01 Apr. 2019)
Drugs.com. Terbutaline (01 Apr. 2019)
ScienceDirect. Ambroxol (01 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
